SCHEMBL2655428

SCHEMBL2655428

COCC(C)Oc1cc(OCc2ccccc2)cc(C(=O)Nc2ccc(C(=O)OC)cn2)c1

nearest known ligand 0.75

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.75
RARA P10276 1/20 0.75
RARB P10826 1/20 0.75
RARG P13631 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2654489 1.00 GCK (0.75) GCKRARARARBRARG
SCHEMBL5430637 0.93 GCK (0.73) GCKRARARARBRARG
SCHEMBL5435282 0.93 GCK (0.88) GCKRARARARBRARG
SCHEMBL2655429 0.91 GCK (0.70) GCKRARARARBRARG
SCHEMBL2651714 0.91 GCK (0.85) GCKRARARARBRARG
SCHEMBL2652506 0.89 GCK (0.81) GCKRARARARBRARG
SCHEMBL14366903 0.89 GCK (0.88) GCKRARARARBRARG
SCHEMBL14520614 0.88 GCK (0.88) GCKRARARARBRARG
SCHEMBL14520615 0.88 GCK (0.88) GCKRARARARBRARG
SCHEMBL14520621 0.87 GCK (0.75) GCKRARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators ASTRAZENECA AB (SE) 2007-11-01 US disclosed
EP-1697324-A1 BENZOYL AMINO PYRIDYL CARBOXYLIC ACID DERIVATIVES USEFUL AS GLUCOKINASE (GLK) ACTIVATORS AstraZeneca AB (SE) 2006-09-06 EP disclosed
WO-2005054200-A1 BENZOYL AMINO PYRIDYL CARBOXYLIC ACID DERIVATIVES USEFUL AS GLUCOKINASE (GLK) ACTIVATORS ASTRAZENECA AB (SE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators GCK, GALK1, PDXK GCK 1/4885RARA 3021/4885RARB 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.